230 related articles for article (PubMed ID: 32099242)
1. A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
Chen Y; Ohara T; Xing B; Qi J; Noma K; Matsukawa A
Acta Med Okayama; 2020 Feb; 74(1):1-6. PubMed ID: 32099242
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of iron metabolism in cancer stem cells.
Recalcati S; Gammella E; Cairo G
Free Radic Biol Med; 2019 Mar; 133():216-220. PubMed ID: 30040994
[TBL] [Abstract][Full Text] [Related]
3. The role of iron chelation in cancer therapy.
Buss JL; Torti FM; Torti SV
Curr Med Chem; 2003 Jun; 10(12):1021-34. PubMed ID: 12678674
[TBL] [Abstract][Full Text] [Related]
4. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells.
El Hout M; Dos Santos L; Hamaï A; Mehrpour M
Semin Cancer Biol; 2018 Dec; 53():125-138. PubMed ID: 30071257
[TBL] [Abstract][Full Text] [Related]
5. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Narusaka T; Ohara T; Noma K; Nishiwaki N; Katsura Y; Kato T; Sato H; Tomono Y; Kikuchi S; Tazawa H; Shirakawa Y; Matsukawa A; Fujiwara T
Int J Cancer; 2021 Jul; 149(2):347-357. PubMed ID: 33662150
[TBL] [Abstract][Full Text] [Related]
6. The medicinal chemistry of novel iron chelators for the treatment of cancer.
Kovacevic Z; Kalinowski DS; Lovejoy DB; Yu Y; Suryo Rahmanto Y; Sharpe PC; Bernhardt PV; Richardson DR
Curr Top Med Chem; 2011; 11(5):483-99. PubMed ID: 21192781
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Iron Chelators on the Biology of Cancer Stem Cells.
Szymonik J; Wala K; Górnicki T; Saczko J; Pencakowski B; Kulbacka J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008527
[TBL] [Abstract][Full Text] [Related]
8. Iron chelators as therapeutic agents for the treatment of cancer.
Richardson DR
Crit Rev Oncol Hematol; 2002 Jun; 42(3):267-81. PubMed ID: 12050019
[TBL] [Abstract][Full Text] [Related]
9. Iron chelation in the treatment of cancer: a new role for deferasirox?
Bedford MR; Ford SJ; Horniblow RD; Iqbal TH; Tselepis C
J Clin Pharmacol; 2013 Sep; 53(9):885-91. PubMed ID: 23740857
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in cancer treatment by iron chelators.
Corcé V; Gouin SG; Renaud S; Gaboriau F; Deniaud D
Bioorg Med Chem Lett; 2016 Jan; 26(2):251-256. PubMed ID: 26684852
[TBL] [Abstract][Full Text] [Related]
11. Iron chelators in cancer chemotherapy.
Buss JL; Greene BT; Turner J; Torti FM; Torti SV
Curr Top Med Chem; 2004; 4(15):1623-35. PubMed ID: 15579100
[TBL] [Abstract][Full Text] [Related]
12. Iron chelators in cancer therapy.
Ibrahim O; O'Sullivan J
Biometals; 2020 Oct; 33(4-5):201-215. PubMed ID: 32757166
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of lipid metabolism alterations in Cancer stem cells.
Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
[TBL] [Abstract][Full Text] [Related]
14. Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin.
Yin M; Liu Y; Chen Y
Free Radic Res; 2021 Mar; 55(3):296-303. PubMed ID: 33818251
[TBL] [Abstract][Full Text] [Related]
15. Expanding horizons in iron chelation and the treatment of cancer: role of iron in the regulation of ER stress and the epithelial-mesenchymal transition.
Lane DJ; Mills TM; Shafie NH; Merlot AM; Saleh Moussa R; Kalinowski DS; Kovacevic Z; Richardson DR
Biochim Biophys Acta; 2014 Apr; 1845(2):166-81. PubMed ID: 24472573
[TBL] [Abstract][Full Text] [Related]
16. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment.
Wang L; Li X; Mu Y; Lu C; Tang S; Lu K; Qiu X; Wei A; Cheng Y; Wei W
J Trace Elem Med Biol; 2019 Dec; 56():131-138. PubMed ID: 31466045
[TBL] [Abstract][Full Text] [Related]
17. The role of iron in cell cycle progression and the proliferation of neoplastic cells.
Le NT; Richardson DR
Biochim Biophys Acta; 2002 Oct; 1603(1):31-46. PubMed ID: 12242109
[TBL] [Abstract][Full Text] [Related]
18. Targeting cancer by binding iron: Dissecting cellular signaling pathways.
Lui GY; Kovacevic Z; Richardson V; Merlot AM; Kalinowski DS; Richardson DR
Oncotarget; 2015 Aug; 6(22):18748-79. PubMed ID: 26125440
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Macromolecular Iron Chelators.
Bulbake U; Singh A; Domb AJ; Khan W
Curr Med Chem; 2019; 26(2):323-334. PubMed ID: 30182850
[TBL] [Abstract][Full Text] [Related]
20. Iron Metabolism in Cancer.
Wang Y; Yu L; Ding J; Chen Y
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
